%0 Journal Article
%A Zhang, Xin-Wen
%A Mohr, Jutta
%A Halama, Niels
%A Koschny, Ronald
%T Analysis of an Unselected Patient Cohort With Advanced Colorectal Carcinoma from a Maximum Care Center.
%J Anticancer research
%V 43
%N 12
%@ 0250-7005
%C Attiki
%I [Verlag nicht ermittelbar]
%M DKFZ-2023-02508
%P 5589 - 5596
%D 2023
%Z #EA:D240#LA:D240#
%X Systemic treatment for metastatic colorectal cancer (CRC) includes chemotherapy in combination with a targeted antibody. Novel targeted therapies and immunotherapies are introduced for specific molecular subgroups. Prognostic relevant determinants are still under investigation.Systemic therapies of an unselected patient cohort with metastatic CRC were retrospectively analyzed. Treatment outcome was evaluated according to time-to-next-treatment (TTNT) and frequency of conversion surgery and compared between subgroups stratified by primary tumor side, molecular profile, sex and age, and metastases sites.More than 50
%K Colorectal cancer (Other)
%K chemotherapy (Other)
%K colorectal liver metastases (Other)
%K metastases (Other)
%K secondary surgery (Other)
%K time-to-next-treatment (Other)
%K tumor sidedness (Other)
%F PUB:(DE-HGF)16
%9 Journal Article
%$ pmid:38030166
%R 10.21873/anticanres.16761
%U https://inrepo02.dkfz.de/record/285693